Quinntunessential
Quinn Elisaa returns to my inbox, this time on behalf of Journal of Clinical Pharmacology and Therapeutics. Two weeks ago, when she and Prissy Wiley last defecated into my mailbox, they were both using the same mailer From address: editor@joapmedtextoa.com.
This time, she's using editor@ijoapmedtext.com. Clearly, this is not due to it being for a different journal, otherwise she wouldn't be sharing with Prissy. I suspect that, like the hoes grinding away in the Belmont bordello, the Medtext molls change mailer addresses—but keep the same Reply-To address—in order to circumvent sender block lists. I cannot imagine what they expect to achieve by doing that.
In this case, variations on MEDTEXT
plus A
; I
; J
; O
; and P
appear to be the rule. If the molls are sharing their mailer address changes, then I fully expect a missive from Prissy to soon appear directly in my junk mail folder.
Until next time.
Subject: Humble Invitation for Manuscript Submission:
Journal of Clinical Pharmacology and Therapeutics (ISSN 2766-8347)
From: Editorial Manager <editor@ijoapmedtext.com>
Reply-To: Editorial Manager <quinnelisaa@medtextopenj.info>
Greetings for the Day!! The Editorial Team of “Journal of Clinical Pharmacology and Therapeutics (ISSN 2766-8347)” Journal is pleased to invite eminent authors like you to submit your valuable contributions to our scholarly journal. If you're interested to write and submit a manuscript, kindly share a Research, Review, Case Report/Case Series/Case Blog/Short Communication (2-4 pages)/Clinical Images (150 words)/Letter to the Editor/Opinion on any topic related to your research interest which falls in the journal scope, so that we can process and publish it for the Volume 03 & Issue 01. We will provide rapid publication of your article and without any interruption in peer review process. We will provide review comments for your article within 3-4 weeks. Journal follows open access policies, double blind peer review process. Published content is available to readers without any subscription. All published articles will be provided with digital object identifier (DOI) issued by Cross ref. I would like to bring to your kind notice that we are planning to release our journal Upcoming Issue on the 15th April, 2022. Kindly send us your manuscript on or before the timeline as an email attachment. We would be very glad to have a positive response from you. Please let me know. Hoping for a favorable reply. With Regards, Quinn Elisaa Journal of Clinical Pharmacology and Therapeutics (ISSN 2766-8347) Medtext Publications LLC 6355 N Clairmont Avenue Chicago, IL 60659 USA
<img width="1" height="1" src="http://194.147.44.97/mail/index.php/campaigns/cb776ojve9078/track-opening/[snip]" alt="" />
Another month, another mailer. This time, Quinn Elisaa's added T
, ironically for the completely opposite purpose to spilling it.
The only thing of note here, and the reason that I'm posting this at all, is to note that Quinn's aware of my reputation and trustworthiness in the field of clinical pharmacology and therapeutics. This is deeply gratifying, especially since I've never been anywhere near a clinical setting, other than as a patient. Should I ever wish to pursue a career in the field, I wonder if I can use her as a character reference. (thinking)
I'm still expecting Prissy to land in my junk mail folder.
Subject: We Eagerly Awaiting for your Manuscript Contribution:
Journal of Clinical Pharmacology and Therapeutics (ISSN 2766-8347)
From: Editorial Manager <editor@medtextpto.com>
Reply-To: Editorial Manager <quinnelisaa@medtextopenj.info>
Greetings for the Day!! We are aware of your scientific reputation and trustworthiness in the field of "Journal of Clinical Pharmacology and Therapeutics (ISSN 2766-8347)" and we would like to invite you to contribute your manuscript for publication in our Upcoming Issue. We kindly request you to share your manuscript like Research, Reviews, Case Series, Case Reports, Technical Reports, Technical Note, 2 pages Editorial, 150 Words Clinical Image or Short Communications or Opinion or Letter to Editor on any topic related to your research interest which falls in the journal scope, so that we can process and publish it for the upcoming issue of our journal. We will provide rapid publication of your article and without any interruption in peer review process. We will provide review comments for your article within 3-4 weeks. Journal follows open access policies, double blind peer review process. Published content is available to readers without any subscription. Kindly attach your manuscript directly to this email or submit through the following Submission E-mail: submissions@medtextpublications.com I would like to bring to your kind notice that we are planning to release our journal Upcoming Issue on the 25th May, 2022. Your prompt response would be highly appreciated. Looking forward to working with you. Kind Regards, Quinn Elisaa Editorial Manager Medtext Publications LLC 6355 N Clairmont Avenue Chicago, IL 60659 USA
<img width="1" height="1" src="http://154.16.77.31/mail/index.php/campaigns/jf295o0d7l219/track-opening/" alt="" />
She's an irrepressable little minx, that Quinn Elisaa. She'd like to appreciate [my] contribution to the scientific community by publishing [my] precious work
. Or is it more the case that she'd like to appreciate my contribution to Medtext Publications LLC by collecting my precious APC fees? (thinking)
She's sure that my quality articles will raise the standards of her webcomic. Which begs the question: what academic or researcher wants to publish in a title that can only be improved by their submission? Yes, I realise that all quality journals of standing achieve that by the consorted contributions of excellent works. But none of them beg for it.
Date: Fri, 12 May 2023 10:20:20 +0000 Subject: *** SPAM *** Dear Dr. [snip], Humble Invitation for Manuscript Submission: Journal of Clinical Pharmacology and Therapeutics (ISSN: 2766-8347) From: Associate Editor <editor@jmedtxtp.com> Reply-To: Associate Editor <quinnelisaa@medtextopenj.info>
Dear Dr. [NAME], Wishes for the day, I am Quinn Elisaa, Editorial Manager of “Journal of Clinical Pharmacology and Therapeutics (ISSN 2766-8347)”. We would like to appreciate your contribution to the scientific community by publishing your precious work. It will be a pleasure to recommend our Journal for your upcoming articles. We are sure your quality articles would raise the standards of our journal. Please submit your valuable manuscript to our Journal. All published articles will be provided with Digital Object Identifier (DOI) issued by Cross ref. We are anticipating receiving your submission on or before 15th June, 2023 for successfully releasing our journal Upcoming Issue. Kindly attach your manuscript directly to this email or submit through the following Submission E-mail: submissions@medtextpublications.com There is no specific topic for this issue, it’s completely depends on your own research work. We are also accepting articles from your colleagues, friends and students. We would be very glad to have a positive response from you. Please let me know. Hoping for a favorable reply. With Regards, Quinn Elisaa Editorial Manager Medtext Publications LLC 6355 N Clairmont Avenue Chicago, IL 60659 USA Unsubscribe
<img width="1" height="1" src="http://98.142.247.146/mail/index.php/campaigns/qv464jyam88c0/track-opening/[snip]" alt="" />
This may be the last I hear of JCPT, but not of Quinn. (grumpy)
American Journal of Surgical Techniques and Case Reports
It took her a week, but Prissy came through in the end, using Quinn Elisaa's—or Elisaa Quinn's—new fake mailer address. And, yes, I found this in my junk mail folder, not my inbox!
According to her: I tried several times, but there is no response from your side, so that i would like to contact you again!!
I doubt that she'll take the hint. (no)
Subject: Short article submission request for
latest issue - American Journal of Surgical Techniques and Case Reports
(ISSN: 2694-4901)
From: American Journal of Surgical Techniques and Case Reports (ISSN:
2694-4901) <editor@ijoapmedtext.com>
Reply-To: American Journal of Surgical Techniques and Case Reports (ISSN:
2694-4901) <prissywiley@medtextopenj.info>
<img width="1" height="1" src="http://192.53.161.180/mail/index.php/campaigns/pa064mnasv595/track-opening/[snip]" alt="" />
The Clinical Ophthalmologist Journal
Rinse and repeat. Quinn Elisaa returns to my inbox with another fake mailer address for The Clinical Ophthalmologist Journal. First, it was editor@joapmedtextoa.com, then editor@ijoapmedtext.com, and now editor@medtextijoap.com.
Subject: We are Reaching you out Regarding Manuscript Submission: The
Clinical Ophthalmologist Journal (ISSN 2692-7985)
From: Editorial Manager <editor@medtextijoap.com>
Reply-To: Editorial Manager <quinnelisaa@medtextopenj.info>
With Regards, Quinn Elisaa Editorial Manager Medtext Publications LLC 6355 N Clairmont Avenue Chicago, IL 60659 USA
I knew it wouldn't be long before I heard from Quinn again, despite unsubscribing
from JCPT. Now she returns for The Clinical Ophthalmologist Journal. Using a different From header to last year's, it's the same as that used yesterday by Medtext's Celestia Grace. Hoes gotta stick together.
Her acknowledgement of my expertise in the webcomic's field suggests she needs the services of an ophthalmologist herself. Except, of course, this is the template shat out to her shitlist. Clearly, unsubscribing has no effect on her spamming on behalf of other comics in her purview; hell's teeth, it may have no effect at all!
So, I'll keep my needed response short and to the point.
Date: Tue, 16 May 2023 12:58:04 +0000 Subject: *** SPAM *** Dear Dr. [snip], We Need your Response Regarding Manuscript Submission: The Clinical Ophthalmologist Journal (ISSN 2692-7985) From: Associate Editor <editor@jpub.jmedtxtp.com> Reply-To: Associate Editor <quinnelisaa@medtextopenj.info>
Dear Dr. [NAME], Salutations from Quinn Elisaa...! We are aware of your scientific reputation and trustworthiness in the field of "The Clinical Ophthalmologist Journal (ISSN 2692-7985)" and we would like to invite you to contribute your manuscript for publication in our Upcoming Issue. We kindly request you to share your manuscript on any topic related to your research interest which falls in the journal scope, so that we can process and publish it for the upcoming issue of our journal. We will provide rapid publication of your article and without any interruption in peer review process. We will provide review comments for your article within 3-4 weeks. Journal follows open access policies, double blind peer review process. We are anticipating receiving your submission on or before 15th June, 2023 for successfully releasing our journal Upcoming Issue. Kindly attach your manuscript directly to this email or submit through the following Submission E-mail: submissions@medtextpublications.com We would be grateful if you consider the proposal and submit your manuscript to the issue and make it successful. Looking forward to working with you. Kind Regards, Quinn Elisaa Editorial Manager Medtext Publications LLC 6355 N Clairmont Avenue Chicago, IL 60659 USA Unsubscribe
<img width="1" height="1" src="http://98.142.247.146/mail/index.php/campaigns/gq794ghd1r31e/track-opening/[snip]" alt="" />
Date: Tue, 16 May 2023 15:51:30 +0200 Subject: Re: *** SPAM *** Dear Dr. [snip], We Need your Response Regarding Manuscript Submission: The Clinical Ophthalmologist Journal (ISSN 2692-7985) To: Associate Editor <quinnelisaa@medtextopenj.info>
Go to hell, you skeevy Indian harlot
Annals of Clinical Case Studies
A year has passed, and Quinn Elisa has returned. This time she's presumptuously awaiting my contribution to yet another dreary [cough] mega journal
of clinical case reports.
I was tempted to reply to the effect of she shouldn't hold her breath or, better still, she should hold her breath. But the witticism would be lost on her. I could just consign it to electronic damnation without further ado. But, instead, I'm going to try that unsubscribe link as an experiment.
Her message was sent to my junk mail folder, not because its From header matched anything she's used previously, but simply because SpamAssassin awarded it a score of 7.4, against 4.0 required.
Date: Wed, 03 May 2023 07:23:58 +0000 Subject: *** SPAM *** Dear Dr. [snip], We are Waiting for Your Manuscript Collaboration: Annals of Clinical Case Studies (ISSN: 2688-1241) From: Associate Editor <editor@jmedtxtp.com> Reply-To: Associate Editor <quinnelisaa@medtextopenj.info>
Dear Dr. [NAME], Greetings!! “Annals of Clinical Case Studies (ISSN 2688-1241)” is a Mega Journal accepts all kinds of articles and follows double blind peer review process within 15-20 days from the date of submission. Now we are in the process of releasing the upcoming issue of the year 2023 (Volume 05 and Issue 05). We would be grateful, if you consider the request and submit your manuscript to the issue and make it successful. Our Journal Indexed in: Google Scholar, CrossRef, Index Copernicus, Semantic Scholar, Publons, Scribd, ISI Indexing, CiteFactor, DRJI, and other sites too. We are anticipating receiving your submission on or before 30th May, 2023 for successfully releasing our journal Upcoming Issue. Kindly attach your manuscript directly to this email or submit through the following Submission E-mail: submissions@medtextpublications.com We are also accepting articles from your colleagues, friends and students. We would be very glad to have a positive response from you. Please let me know. Hoping for a favorable reply. With Regards, Quinn Elisaa Medtext Publications LLC 6355 N Clairmont Avenue Chicago, IL 60659 USA Unsubscribe
<img width="1" height="1" src="http://98.142.247.146/mail/index.php/campaigns/be302rz0s05c2/track-opening/[snip]" alt=3D"" />
Right, it looks like this unsubscription is limited to the specific webcomic, not Medtext's general shitlist. And the cheeky fuckers offer the opportunity to subscribe again
, despite me not having actually subscribed in the first instance. Hrmph! (angry)
